Investigación Cardiovascular
![Foto de Investigación Cardiovascular](/img/grupo.png)
![Foto de Jagiellonian University](/img/noimage_org.png)
Jagiellonian University
Cracovia, PoloniaPublicacións en colaboración con investigadores/as de Jagiellonian University (14)
2024
-
Health-Status Outcomes in Older Patients with Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy
Circulation: Cardiovascular Quality and Outcomes, Vol. 17, Núm. 7, pp. e010490
2023
-
Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients
European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 1, pp. 22-37
-
Worldwide survey on implantation of and outcomes for conduction system pacing with His bundle and left bundle branch area pacing leads
Journal of Interventional Cardiac Electrophysiology, Vol. 66, Núm. 7, pp. 1589-1600
2022
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study
European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316
2021
-
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: The ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
European Heart Journal, Vol. 42, Núm. 44, pp. 4536-4549
2020
-
Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five-year clinical outcomes of the randomised ABSORB II trial
EuroIntervention, Vol. 16, Núm. 11, pp. E938-E941
-
Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent
Atherosclerosis, Vol. 312, pp. 79-89
2019
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study
EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252
2018
2017
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134
-
Comparison of everolimus-eluting bioresorbable scaffolds with everolimuseluting metallic stents for treatment of coronary artery stenosis: Three-year follow-up of the ABSORB II randomized trial
Bioresorbable Scaffolds: From Basic Concept to Clinical Applications (CRC Press), pp. 224-237
2016
-
A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy
Cardiovascular Revascularization Medicine, Vol. 17, Núm. 6, pp. 355-361
-
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
The Lancet, Vol. 388, Núm. 10059, pp. 2479-2491
2015
-
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
The Lancet, Vol. 385, Núm. 9962, pp. 43-54